1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Vitara

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Philadelphia PA US

Primary Industry

Medical Devices & Equipment

About

Based in Pennsylvania, US, and founded in 2019, Vitara Biomedical, Inc. develops therapeutic medical devices for premature infants and provides physiological procedures for neonatal care for newborns to help lower mortality and comorbidities. In July 2022, Vitara Biomedical, Inc. raised USD 24.99 million in venture funding from investors. James S. McGlone is the founder and CEO of the company. The company is developing a therapeutic platform for premature infants that is inspired by natural physiological processes and has the potential to transform neonatal care. The organization plans to use the July 2022 funding to advance its artificial womb technology for premature babies.
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.vitara.com
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.